BAC Holds Off on Dividend Hike After Stress Tests, DeepValue Report Flags Downside NII Risk

What happened

After the Federal Reserve's stress test results, most large banks announced dividend increases, but Bank of America has held off, maintaining its capital flexibility according to a July 2 article. The DeepValue Master Report, based on the latest 10-Q and market data, characterizes BAC as a 'WAIT' with an attractive entry near $45, currently trading at $49.84, highlighting the stock's asymmetric downside risk from faster rate cuts. The report emphasizes that BAC's NII sensitivity is skewed: an instantaneous -100 bps rate shock reduces 12-month NII by $2.0B, while a +100 bps adds only $0.4B, making the stock vulnerable if the Fed eases more than expected. While BAC's 1Q26 results were strong (net income $8.6B, NII up, credit improving), the report cautions that the next 3-6 months are critical for confirming the NII floor and expense trajectory. The stress test results, due by June 30, 2026, and the 2Q26 update on sensitivity and expenses will be decisive signals; BAC's holdout on dividends suggests management is preserving optionality amid this uncertainty.

Implication

The implication for investors is to maintain a cautious stance. While BAC passed the stress test, its decision not to raise dividends like peers suggests management is hedging against potential rate cuts. The DeepValue report's analysis shows that BAC's earnings are more sensitive to downside rate moves than upside, meaning that any further Fed easing could compress NII significantly. The attractive entry is near $45, a 10% downside from current levels, which provides a better risk/reward given the uncertainties. Investors should wait for the 2Q26 results, due in mid-July, for updated sensitivity tables and expense metrics. If those confirm that NII sensitivity has not worsened and expenses remain controlled, BAC could re-rate higher, but until then, patience is warranted.

Thesis delta

The core thesis remains unchanged: BAC is a solid bank with a diversified earnings base, but its asymmetric rate sensitivity and expense growth are near-term overhangs. The news that BAC is a holdout on dividend hikes, unlike peers, adds a layer of caution, reinforcing the view that management sees potential headwinds. This does not change the 'WAIT' rating but reinforces the need for a re-assessment window to confirm the NII and expense trajectory.